Health knowledge made personal

Irv Arons Healthy Living Professional

Peabody, Massachusetts
I am now retired after spending the last 30 years consulting in ophthalmic and medical lasers and ophthalmic technologies. I was on the staff of Arthur D. Little for 25 years, heading its Ophthalmic and Medical Laser Consulting Group. After my retirement from ADL, I ran my own consulting firm,... Full Bio
› Share page: Email Digg del.icio.us Reddit icon StumbleUpon Technorati

Stem Cells in Ophthalmology Update 21: Clinical Trial Details

As with my inquiry into clinical trials underway using gene therapy in ophthalmology, Table 3 Gene Therapy in Ophthalmology - Ongoing Clinical...

Gene Therapy in Ophthalmology Update 11: Clinical Trial Details

I have found fifteen gene therapy clinical trials underway to treat various eye disorders. In thinking about this, I wondered how many patients...

Stem Cells in Ophthalmology Update 20: ACT Adds Mass Eye & Ear as Fourth Clinical Site for Dry AMD Trials

As announced this morning, Advanced Cell Technology said that Mass Eye & Ear Infirmary had received IRB approval to become the fourth clinical...

CATT Update 16: Two-year Results Published in Ophthalmology – No Significant Difference Found Between Avastin and Lucentis

For those of you who have been following my writings on Avastin vs. Lucentis and on the CATT Study, the two-year results comparing Avastin to...

Iluvien Update 6: First European Marketing Approval Obtained

While U.S. marketing approval appears to be out of reach for Alimera and pSivida for Iluvien for the sustained release treatment of diabetic...
Irv Arons's Whiteboard

Communities (1)

Friends

Irv Arons has no friends yet : (